Jean Charles Samuelian Werve picked an odd second act. In his twenties he was building featherweight titanium airplane seats. By his thirties he was trying to break into French health insurance, an industry that hadn’t let a new independent player through the door since the 1980s. Ten years on, that second bet, a company called Alan, is worth north of €5 billion.
The number landed in March 2026, when Alan said it had raised more than €100 million in fresh funding led by its longtime backer Index Ventures, according to Bloomberg. The company also said it had crossed one million members and brought in €785 million in annual recurring revenue last year, a 53 percent jump from 2024, and that its French business, still its biggest, had finally turned a profit.
